How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 43 people who said how it went. 9 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 16 | 37% |
| Helped | 16 | 37% |
| No change | 5 | 12% |
| Worse | 6 | 14% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 28 | 39 | |
| Recovery stories | 4 | 4 |
Did it last, for everyone it helped?
- It wore off for 14 of the 32 people it helped: 8 who credit it for their improvement, 6 who don’t.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 36 people who said how it went. 8 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 10 | 28% |
| Helped | 15 | 41% |
| No change | 5 | 14% |
| Worse | 6 | 17% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 24 | 35 | |
| Recovery stories | 1 | 1 |
Did it last, for everyone it helped?
- It wore off for 10 of the 25 people it helped: 4 who credit it for their improvement, 6 who don’t.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 7 people who said how it went. 1 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 6 | 86% |
| Helped | 1 | 14% |
| No change | 0 | 0% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 4 | 4 | |
| Recovery stories | 3 | 3 |
Did it last, for everyone it helped?
- It wore off for 4 of the 7 people it helped, all of whom credit it for their improvement.
Ask about this treatment
Among the 15 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 7 say it helped them most; 8 say it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 2 | 13% |
| Near normal | 1 | 7% |
| Much better | 0 | 0% |
| Somewhat better | 5 | 33% |
| Relapsed | 7 | 47% |
Did it last?
- 8 of the 15 who credit it said its benefit wore off (6 of them among the 7 who relapsed).
- 5 of the 15 who credit it say they still need to keep doing something (not always this) to stay well.
Among the 10 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 2 say it helped them most; 8 say it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 1 | 10% |
| Near normal | 1 | 10% |
| Much better | 0 | 0% |
| Somewhat better | 4 | 40% |
| Relapsed | 4 | 40% |
Did it last?
- 4 of the 10 who credit it said its benefit wore off (3 of them among the 4 who relapsed).
- 3 of the 10 who credit it say they still need to keep doing something (not always this) to stay well.
Among the 5 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 5 say it helped them most.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 1 | 20% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 1 | 20% |
| Relapsed | 3 | 60% |
Did it last?
- 4 of the 5 who credit it said its benefit wore off (including the 3 who relapsed).
- 2 of the 5 who credit it say they still need to keep doing something (not always this) to stay well.
Everyone · not split by condition
By how ill people were
Only the 15 who credit it, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall, not the effect of this one treatment.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Mild | 1 | 0%, few people | |
| Moderate | 7 | 29%, few people | |
| Severe | 6 | 17%, few people | |
| Not stated | 1 | 0%, few people |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Mild | Somewhat better | 1 of 1 | 100% |
| Moderate | Recovered | 1 of 7 | 15% |
| Moderate | Near normal | 1 of 7 | 14% |
| Moderate | Somewhat better | 3 of 7 | 43% |
| Moderate | Relapsed | 2 of 7 | 28% |
| Severe | Recovered | 1 of 6 | 17% |
| Severe | Somewhat better | 1 of 6 | 16% |
| Severe | Relapsed | 4 of 6 | 67% |
| Not stated | Relapsed | 1 of 1 | 100% |
Everyone · not split by condition
What people started next
11 of the 43 people who said how it went saw no change or got worse. 6 of those 11 say what they started next.
Everyone · not split by condition
Adverse events
What people said went wrong, in their own words.
12 of 52
people who wrote about taking it described a problem they tied to it
The serious kinds
Worth telling a doctor about straight away.
Heart rhythm problems
1 person“Tachycardia is worse now, that's the most I've noticed.”
— Ocean 33556
The serious kinds are a death, suicidal thoughts or an attempt, a hospital stay, an ER visit, an allergic reaction or anaphylaxis, heart rhythm, liver or kidney, blood count, mood or psychiatric, or refeeding or deficiency problems, and being made much worse: a large worsening such as a crash lasting weeks or more.
Other kinds
Unpleasant effects people tied to it, the most serious first.
Made symptoms worse · 5Withdrawal problems · 1Gut side effects · 2Side effects · 5 Show all 4Hide
Made symptoms worse
5 people“I tried molnupiravir the first few days were pretty rough with symptom exacerbation”
— Creek 44516 “I tolerated 2 doses, but then I had the same kind of reaction on the 3rd dose so I had to stop.”
— Harbor 61138 Show 3 moreShow fewer
“I took a 5 day course of Lagevrio in early May and by mid-May I went into the worst flare since symptom onset in the late summer of 2022.”
— Otter 14299 “I also tried acyclovir (almost nothing, maybe some anti-inflammatory action) and molnupiravir (dizzyness, and relapse next day).”
— Dusk 37295 “IMHO shitty drug. I feel VERY dizzy, and WAY WORSE day after”
— Lagoon 63954 Withdrawal problems
1 person“I had great benefits taking both Pax and Molnupiravir but suffered terrible rebound after stopping it.”
— Teodora Gut side effects
2 people“Side effect was tummy upset but sooooo worth it.”
— Horizon 44452 “Molnupiravir. It worked great when I first took it then with time it pretty much stopped being effective. But it hurt my stomach lining.”
— Hawk 26364 Side effects
5 people“after molnupiravir got ear pain”
— Creek 44516 “I tried molnupiravir a couple of days after I tested positive for COVID in January, 2023 and I developed severe headaches and diarrhea that subsided 48 hours after I stopped the drug.”
— Trail 92105 Show 3 moreShow fewer
“the fatigue is a brick to the face ... everything hurts to hear”
— Maple 33248 “In general, both meds are pretty toxic in terms of their general feeling.”
— Teodora “after I stopped taking the molnupiravir I began to get really gnarly headaches and sometimes migraines.”
— Plover 95418
All posts · not split by condition
How often it comes up
Posts that mention Molnupiravir (Lagevrio), per 1,000 posts each month. Hover or tap a point for the count.
| Month | Posts mentioning it | All posts | Per 1,000 |
|---|---|---|---|
| Oct 2009 | 0 | 105 | 0 |
| Jan 2010 | 0 | 141 | 0 |
| Feb 2010 | 0 | 113 | 0 |
| Jun 2011 | 0 | 109 | 0 |
| Nov 2011 | 0 | 124 | 0 |
| Dec 2011 | 0 | 199 | 0 |
| Jan 2012 | 0 | 232 | 0 |
| Feb 2012 | 0 | 103 | 0 |
| Mar 2012 | 0 | 190 | 0 |
| Apr 2012 | 0 | 162 | 0 |
| May 2012 | 0 | 375 | 0 |
| Jun 2012 | 0 | 238 | 0 |
| Jul 2012 | 0 | 240 | 0 |
| Aug 2012 | 0 | 485 | 0 |
| Sep 2012 | 0 | 561 | 0 |
| Oct 2012 | 0 | 526 | 0 |
| Nov 2012 | 0 | 514 | 0 |
| Dec 2012 | 0 | 699 | 0 |
| Jan 2013 | 0 | 533 | 0 |
| Feb 2013 | 0 | 447 | 0 |
| Mar 2013 | 0 | 429 | 0 |
| Apr 2013 | 0 | 499 | 0 |
| May 2013 | 0 | 606 | 0 |
| Jun 2013 | 0 | 609 | 0 |
| Jul 2013 | 0 | 616 | 0 |
| Aug 2013 | 0 | 577 | 0 |
| Sep 2013 | 0 | 364 | 0 |
| Oct 2013 | 0 | 536 | 0 |
| Nov 2013 | 0 | 385 | 0 |
| Dec 2013 | 0 | 519 | 0 |
| Jan 2014 | 0 | 944 | 0 |
| Feb 2014 | 0 | 821 | 0 |
| Mar 2014 | 0 | 425 | 0 |
| Apr 2014 | 0 | 361 | 0 |
| May 2014 | 0 | 617 | 0 |
| Jun 2014 | 0 | 489 | 0 |
| Jul 2014 | 0 | 444 | 0 |
| Aug 2014 | 0 | 622 | 0 |
| Sep 2014 | 0 | 507 | 0 |
| Oct 2014 | 0 | 678 | 0 |
| Nov 2014 | 0 | 567 | 0 |
| Dec 2014 | 0 | 629 | 0 |
| Jan 2015 | 0 | 760 | 0 |
| Feb 2015 | 0 | 873 | 0 |
| Mar 2015 | 0 | 1,276 | 0 |
| Apr 2015 | 0 | 984 | 0 |
| May 2015 | 0 | 1,496 | 0 |
| Jun 2015 | 0 | 1,046 | 0 |
| Jul 2015 | 0 | 1,211 | 0 |
| Aug 2015 | 0 | 998 | 0 |
| Sep 2015 | 0 | 1,060 | 0 |
| Oct 2015 | 0 | 1,255 | 0 |
| Nov 2015 | 0 | 1,246 | 0 |
| Dec 2015 | 0 | 924 | 0 |
| Jan 2016 | 0 | 1,282 | 0 |
| Feb 2016 | 0 | 1,051 | 0 |
| Mar 2016 | 0 | 1,002 | 0 |
| Apr 2016 | 0 | 998 | 0 |
| May 2016 | 0 | 1,045 | 0 |
| Jun 2016 | 0 | 1,230 | 0 |
| Jul 2016 | 0 | 1,619 | 0 |
| Aug 2016 | 0 | 1,729 | 0 |
| Sep 2016 | 0 | 1,785 | 0 |
| Oct 2016 | 0 | 1,220 | 0 |
| Nov 2016 | 0 | 1,092 | 0 |
| Dec 2016 | 0 | 1,211 | 0 |
| Jan 2017 | 0 | 1,660 | 0 |
| Feb 2017 | 0 | 1,988 | 0 |
| Mar 2017 | 0 | 2,078 | 0 |
| Apr 2017 | 0 | 2,133 | 0 |
| May 2017 | 0 | 2,370 | 0 |
| Jun 2017 | 0 | 2,194 | 0 |
| Jul 2017 | 0 | 2,183 | 0 |
| Aug 2017 | 0 | 2,466 | 0 |
| Sep 2017 | 0 | 2,189 | 0 |
| Oct 2017 | 0 | 3,042 | 0 |
| Nov 2017 | 0 | 1,976 | 0 |
| Dec 2017 | 0 | 2,112 | 0 |
| Jan 2018 | 0 | 2,620 | 0 |
| Feb 2018 | 0 | 2,155 | 0 |
| Mar 2018 | 0 | 2,613 | 0 |
| Apr 2018 | 0 | 2,251 | 0 |
| May 2018 | 0 | 2,828 | 0 |
| Jun 2018 | 0 | 3,871 | 0 |
| Jul 2018 | 0 | 3,067 | 0 |
| Aug 2018 | 0 | 3,757 | 0 |
| Sep 2018 | 0 | 3,512 | 0 |
| Oct 2018 | 0 | 3,261 | 0 |
| Nov 2018 | 0 | 2,861 | 0 |
| Dec 2018 | 0 | 2,754 | 0 |
| Jan 2019 | 0 | 3,672 | 0 |
| Feb 2019 | 0 | 2,715 | 0 |
| Mar 2019 | 0 | 3,317 | 0 |
| Apr 2019 | 0 | 3,141 | 0 |
| May 2019 | 0 | 3,855 | 0 |
| Jun 2019 | 0 | 3,392 | 0 |
| Jul 2019 | 0 | 3,312 | 0 |
| Aug 2019 | 0 | 3,943 | 0 |
| Sep 2019 | 0 | 4,035 | 0 |
| Oct 2019 | 0 | 3,922 | 0 |
| Nov 2019 | 0 | 3,508 | 0 |
| Dec 2019 | 0 | 3,659 | 0 |
| Jan 2020 | 0 | 4,650 | 0 |
| Feb 2020 | 0 | 4,374 | 0 |
| Mar 2020 | 0 | 4,475 | 0 |
| Apr 2020 | 0 | 3,690 | 0 |
| May 2020 | 0 | 4,543 | 0 |
| Jun 2020 | 0 | 5,701 | 0 |
| Jul 2020 | 0 | 6,104 | 0 |
| Aug 2020 | 0 | 10,333 | 0 |
| Sep 2020 | 0 | 11,958 | 0 |
| Oct 2020 | 0 | 14,568 | 0 |
| Nov 2020 | 0 | 16,546 | 0 |
| Dec 2020 | 0 | 20,764 | 0 |
| Jan 2021 | 0 | 24,562 | 0 |
| Feb 2021 | 1 | 24,672 | 0.04 |
| Mar 2021 | 0 | 29,476 | 0 |
| Apr 2021 | 0 | 28,509 | 0 |
| May 2021 | 1 | 25,791 | 0.04 |
| Jun 2021 | 2 | 27,871 | 0.07 |
| Jul 2021 | 0 | 27,220 | 0 |
| Aug 2021 | 0 | 30,808 | 0 |
| Sep 2021 | 3 | 30,074 | 0.10 |
| Oct 2021 | 2 | 22,132 | 0.09 |
| Nov 2021 | 5 | 27,722 | 0.18 |
| Dec 2021 | 4 | 31,872 | 0.13 |
| Jan 2022 | 8 | 42,317 | 0.19 |
| Feb 2022 | 2 | 38,697 | 0.05 |
| Mar 2022 | 2 | 44,305 | 0.05 |
| Apr 2022 | 3 | 44,333 | 0.07 |
| May 2022 | 3 | 50,594 | 0.06 |
| Jun 2022 | 2 | 49,058 | 0.04 |
| Jul 2022 | 4 | 53,485 | 0.07 |
| Aug 2022 | 2 | 54,455 | 0.04 |
| Sep 2022 | 1 | 56,936 | 0.02 |
| Oct 2022 | 15 | 58,511 | 0.26 |
| Nov 2022 | 3 | 59,198 | 0.05 |
| Dec 2022 | 1 | 61,576 | 0.02 |
| Jan 2023 | 1 | 61,004 | 0.02 |
| Feb 2023 | 10 | 50,133 | 0.20 |
| Mar 2023 | 3 | 59,925 | 0.05 |
| Apr 2023 | 10 | 54,251 | 0.18 |
| May 2023 | 5 | 57,768 | 0.09 |
| Jun 2023 | 2 | 52,679 | 0.04 |
| Jul 2023 | 6 | 56,401 | 0.11 |
| Aug 2023 | 9 | 65,435 | 0.14 |
| Sep 2023 | 10 | 61,835 | 0.16 |
| Oct 2023 | 7 | 58,419 | 0.12 |
| Nov 2023 | 5 | 53,662 | 0.09 |
| Dec 2023 | 16 | 60,643 | 0.26 |
| Jan 2024 | 14 | 71,818 | 0.19 |
| Feb 2024 | 9 | 70,045 | 0.13 |
| Mar 2024 | 3 | 68,261 | 0.04 |
| Apr 2024 | 7 | 64,374 | 0.11 |
| May 2024 | 6 | 67,698 | 0.09 |
| Jun 2024 | 3 | 64,720 | 0.05 |
| Jul 2024 | 11 | 65,335 | 0.17 |
| Aug 2024 | 19 | 68,517 | 0.28 |
| Sep 2024 | 7 | 70,168 | 0.10 |
| Oct 2024 | 4 | 72,607 | 0.06 |
| Nov 2024 | 1 | 71,802 | 0.01 |
| Dec 2024 | 8 | 74,401 | 0.11 |
| Jan 2025 | 8 | 77,909 | 0.10 |
| Feb 2025 | 2 | 65,110 | 0.03 |
| Mar 2025 | 1 | 69,905 | 0.01 |
| Apr 2025 | 7 | 61,606 | 0.11 |
| May 2025 | 0 | 65,733 | 0 |
| Jun 2025 | 5 | 60,540 | 0.08 |
| Jul 2025 | 1 | 62,105 | 0.02 |
| Aug 2025 | 3 | 64,578 | 0.05 |
| Sep 2025 | 6 | 61,704 | 0.10 |
| Oct 2025 | 5 | 59,204 | 0.08 |
| Nov 2025 | 1 | 58,944 | 0.02 |
| Dec 2025 | 1 | 62,830 | 0.02 |
| Jan 2026 | 6 | 63,321 | 0.09 |
| Feb 2026 | 4 | 53,085 | 0.08 |
| Mar 2026 | 6 | 59,208 | 0.10 |
| Apr 2026 | 1 | 53,989 | 0.02 |
| May 2026 | 4 | 57,541 | 0.07 |
| Jun 2026 | 3 | 55,301 | 0.05 |
| Jul 2026 | 9 | 56,391 | 0.16 |
| Aug 2026 | 3 | 56,825 | 0.05 |
| Sep 2026 | 0 | 57,143 | 0 |
Forum and Reddit posts, 4,007,898 in all, counted per month. A mention means the post names the treatment, not that the writer took it. All trends
20 of the 52 people who tried it
See all 52 stories-
Bedbound after COVID with ME/CFS, now somewhat better on valtrex
He had ME/CFS for about ten years, starting overnight, with a remission that ended after bowel surgery. COVID in 2024 left him bedbound for six to eight weeks; on valtrex, which he credits most, plus molnupiravir and Novavax, he improved to mild. He worked…
-
Too ill to work with long COVID, now somewhat better with rest and pacing
Crane 66587 developed long COVID in 2022 and became too ill to work, with POTS, tachycardia, brain fog, head pressure and flu-like crashes after overdoing it. They regressed around year one, then focused on rest and pacing; things changed at the three-year…
-
Mostly housebound with long COVID, helped by pacing, then worse after reinfection
Horizon 44452, a woman in Melbourne, fell ill with long COVID in 2022, developing pericarditis and severe PEM, with early POTS and possible MCAS/orthostatic intolerance. Mostly housebound for long stretches, she could walk or stand only 1–2 minutes and not…
-
List of ME/CFS Recovery and Improvement Stories (page 7-8 discussion)
godlovesatrier fell ill after glandular fever in 2016 and was severe for about 18 months before building back to full-time work with herbal antivirals, high-dose thiamine, the Born Free protocol, valtrex and molnupiravir. He reached about 80–90% in…
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
Teodora described about five years of long COVID with PEM, brain fog, chest pain, fatigue and low white cell counts. Antibiotics for chronic infections brought some progress but she slid back when she stopped them. Paxlovid and molnupiravir gave her best…
-
Cured my Echovirus 11 (pretty sure)
sometexan84 fell ill in 2019 after an enterovirus infection that he says corticosteroid shots for sinus trouble made chronic; at his worst he could not work or care for his children. He credits peginterferon lambda, an Echovirus 11 antiviral cocktail and…
-
ME/CFS able to work part-time, then COVID pain, fog; amitriptyline, gabapentin no benefit
They had ME/CFS since 2012, not severe, and had stabilised enough to work part-time. After COVID in late July 2026 they developed burning, pressure-sensitive pain, vertigo, light and noise sensitivity, brain fog and broken sleep, and said their baseline had…
-
Long COVID over five years, still unable to hold a job; no lasting improvement
Has had long COVID for more than five years, starting right after infection, and is still ill, mildly affected but unable to hold a job. Paxlovid reduced chest pain, fatigue and PEM within a day, while molnupiravir helped after initial worsening; the benefit…
-
Severe long COVID with CFS-like symptoms, still severely affected and far from baseline
After ICU COVID pneumonia in 2022, this physician developed severe long COVID with CFS-like symptoms and neuropathy, leaving him able to work only a few hours a day. Mild hyperbaric oxygen with Niagen and later monoclonal antibodies each produced brief…
-
Long COVID pain and pooling at six years, somewhat better with pentoxifylline and kratom
Six years into long COVID, with a pain- and pooling-dominated neurovascular subtype, they tried many drugs, supplements, diets and therapies without luck. Pentoxifylline and the hepatitis C antiviral Ledifos helped pain and pooling, and kratom further cut…
-
Long COVID brain fog and PEM, rest helped then crashes brought relapse, still housebound
Ill with long COVID since 2022 after COVID infections in 2022, 2023 and 2024, they kept working as a paralegal until brain fog, exhaustion and post-exertional malaise forced retirement in January 2026. Medical leave and rest lifted them from about 25% to 60%…
-
Long COVID head pressure and insomnia; Ambien and nicotine patches helped some
Trail 92105 caught COVID in January 2023 and developed neurological long COVID: head pressure and headaches, head buzzing and some ear ringing, loss of taste and smell, and severe insomnia. Supplements gave mixed results; antihistamines did not help and…
-
Long COVID pain eased a little by low-dose naltrexone, now relapsed after reinfection
Lagoon 81602 dates their illness to mRNA covid vaccination in March 2021 and was diagnosed with long COVID six months after an infection in early 2024. Nightly low-dose naltrexone 4.5 mg and low-dose compounded capsules (20 mg) eased pain a little; they now…
-
Long COVID with dysautonomia and memory problems, somewhat better on low-dose naltrexone
Cedar 83007 caught COVID in March 2020 and has had long COVID for over six years, with dysautonomia, POTS, MCAS, inflammatory bowel disease, chronic chest infections and memory problems. They say some symptoms improved and others worsened over time, with an…
-
Months unable to leave room with long COVID, much better after bivalent booster
A woman in her mid-30s with pre-existing ME/CFS caught COVID in January 2022, was mostly unconscious for three weeks and spent months unable to leave her room; a stroke worsened her language and memory problems. She credited the bivalent/omicron booster with…
-
Long COVID improved, then relapsed to mostly in bed and housebound after a third infection
Harbor 61138, a 32-year-old woman, had COVID in May 2022 and October 2022 and developed long COVID after the October infection, with dysautonomia, tachycardia, brain zaps, panic, GI issues and derealization; she recovered by summer 2023. After a third…
-
Bedbound four years with long COVID, still cognitively impaired; no benefit from drugs
Mesa 40179 has had long COVID for about six years, with MCAS from the start and dysautonomia, and severe cognitive problems; they were bed bound for four years. Dozens of psychiatric drugs and supplements gave no benefit; creatine was the only thing that…
-
Wheelchair-bound by long COVID, much better with diet and exercise
Severe COVID in November 2021 put them in hospital for nine days with double pneumonia, leaving lung scarring, breathlessness and oxygen dependence; later fatigue and dizzy spells proved to be severe anaemia, treated with iron. A mild September 2024…
-
ME/CFS fatigue: tirzepatide gave no symptom relief
A Reddit user with ME/CFS and ADHD, in their mid-40s, said Vyvanse gave them enough energy for a part-time job, though they remained fatigued. Two COVID infections did not make them worse, and Lagevrio made each illness tolerable. Tirzepatide, taken for over…
-
Long COVID burning hands and feet, somewhat better with a drug stack and nicotine patches
This user has had long COVID since 2020, with painful burning hands and feet, dysautonomia, histamine intolerance and, after a stressful event, 14 months of constant dizziness. A self-bought stack of sofosbuvir/ledipasvir, pentoxifylline and valsartan…
These are the newest 6 of the 15 who credit Molnupiravir (Lagevrio) for their improvement, then the newest 14 of the 37 who tried it without crediting it, in about the same proportion as the full list.
20 of the 44 people who tried it
See all 44 stories-
Too ill to work with long COVID, now somewhat better with rest and pacing
Crane 66587 developed long COVID in 2022 and became too ill to work, with POTS, tachycardia, brain fog, head pressure and flu-like crashes after overdoing it. They regressed around year one, then focused on rest and pacing; things changed at the three-year…
-
Mostly housebound with long COVID, helped by pacing, then worse after reinfection
Horizon 44452, a woman in Melbourne, fell ill with long COVID in 2022, developing pericarditis and severe PEM, with early POTS and possible MCAS/orthostatic intolerance. Mostly housebound for long stretches, she could walk or stand only 1–2 minutes and not…
-
Dr Chia finds enterovirus ME/CFS patients given remdesivir remain in remission (Teodora)
Teodora described about five years of long COVID with PEM, brain fog, chest pain, fatigue and low white cell counts. Antibiotics for chronic infections brought some progress but she slid back when she stopped them. Paxlovid and molnupiravir gave her best…
-
Long COVID, too disabled to work, now somewhat better after molnupiravir
Dusk 30640 has had long COVID since 2022 and was too disabled to work. A five-day course of molnupiravir for a June 2025 reinfection left her better than before the infection. In April 2026 Mounjaro at 2.5 mg made her more tired with apparent blood sugar…
-
Long COVID housebound and sometimes bedbound, somewhat better with a beta blocker
Eagle 30515 has had long COVID since September 2020, becoming housebound and at times bedbound with fatigue, pain, breathlessness, palpitations, vertigo and vomiting. Antidepressants (Wellbutrin, later Cymbalta) gave small gains in mood, and a beta blocker…
-
Long COVID over five years, still unable to hold a job; no lasting improvement
Has had long COVID for more than five years, starting right after infection, and is still ill, mildly affected but unable to hold a job. Paxlovid reduced chest pain, fatigue and PEM within a day, while molnupiravir helped after initial worsening; the benefit…
-
Severe long COVID with CFS-like symptoms, still severely affected and far from baseline
After ICU COVID pneumonia in 2022, this physician developed severe long COVID with CFS-like symptoms and neuropathy, leaving him able to work only a few hours a day. Mild hyperbaric oxygen with Niagen and later monoclonal antibodies each produced brief…
-
Long COVID pain and pooling at six years, somewhat better with pentoxifylline and kratom
Six years into long COVID, with a pain- and pooling-dominated neurovascular subtype, they tried many drugs, supplements, diets and therapies without luck. Pentoxifylline and the hepatitis C antiviral Ledifos helped pain and pooling, and kratom further cut…
-
Long COVID brain fog and PEM, rest helped then crashes brought relapse, still housebound
Ill with long COVID since 2022 after COVID infections in 2022, 2023 and 2024, they kept working as a paralegal until brain fog, exhaustion and post-exertional malaise forced retirement in January 2026. Medical leave and rest lifted them from about 25% to 60%…
-
Long COVID head pressure and insomnia; Ambien and nicotine patches helped some
Trail 92105 caught COVID in January 2023 and developed neurological long COVID: head pressure and headaches, head buzzing and some ear ringing, loss of taste and smell, and severe insomnia. Supplements gave mixed results; antihistamines did not help and…
-
Long COVID pain eased a little by low-dose naltrexone, now relapsed after reinfection
Lagoon 81602 dates their illness to mRNA covid vaccination in March 2021 and was diagnosed with long COVID six months after an infection in early 2024. Nightly low-dose naltrexone 4.5 mg and low-dose compounded capsules (20 mg) eased pain a little; they now…
-
Long COVID with dysautonomia and memory problems, somewhat better on low-dose naltrexone
Cedar 83007 caught COVID in March 2020 and has had long COVID for over six years, with dysautonomia, POTS, MCAS, inflammatory bowel disease, chronic chest infections and memory problems. They say some symptoms improved and others worsened over time, with an…
-
Months unable to leave room with long COVID, much better after bivalent booster
A woman in her mid-30s with pre-existing ME/CFS caught COVID in January 2022, was mostly unconscious for three weeks and spent months unable to leave her room; a stroke worsened her language and memory problems. She credited the bivalent/omicron booster with…
-
Long COVID improved, then relapsed to mostly in bed and housebound after a third infection
Harbor 61138, a 32-year-old woman, had COVID in May 2022 and October 2022 and developed long COVID after the October infection, with dysautonomia, tachycardia, brain zaps, panic, GI issues and derealization; she recovered by summer 2023. After a third…
-
Bedbound four years with long COVID, still cognitively impaired; no benefit from drugs
Mesa 40179 has had long COVID for about six years, with MCAS from the start and dysautonomia, and severe cognitive problems; they were bed bound for four years. Dozens of psychiatric drugs and supplements gave no benefit; creatine was the only thing that…
-
Wheelchair-bound by long COVID, much better with diet and exercise
Severe COVID in November 2021 put them in hospital for nine days with double pneumonia, leaving lung scarring, breathlessness and oxygen dependence; later fatigue and dizzy spells proved to be severe anaemia, treated with iron. A mild September 2024…
-
Long COVID burning hands and feet, somewhat better with a drug stack and nicotine patches
This user has had long COVID since 2020, with painful burning hands and feet, dysautonomia, histamine intolerance and, after a stressful event, 14 months of constant dizziness. A self-bought stack of sofosbuvir/ledipasvir, pentoxifylline and valsartan…
-
Long COVID with severe anxiety and insomnia, somewhat better on clonidine and sleep aids
Hill 37755 caught COVID in late August 2025 and within days had severe fight-or-flight anxiety and diarrhoea; insomnia and blood-pressure spikes came later, and they had repeated psychiatric hospitalisations. Lexapro, propranolol and benzodiazepines helped…
-
Repeated COVID infections and no improvement on Lagevrio, asking if it is long COVID
They caught COVID-19 from their father in mid-March and it eased within a week, but a second infection came in April when the weather turned cold and a third five days before posting, which they said was killing them. They had been taking Lagevrio and said…
-
Unable to work or leave the house with long COVID, partly better after metformin and LDN
Swan 12591 developed long COVID and interstitial cystitis 30 days after a second Moderna shot in early 2022. She became unable to work or leave the house, and a COVID infection nine months later amplified symptoms and set recovery back six months. Metformin,…
These are the newest 5 of the 10 who credit Molnupiravir (Lagevrio) for their improvement, then the newest 15 of the 34 who tried it without crediting it, in about the same proportion as the full list.
All 8 people who tried it
-
Bedbound after COVID with ME/CFS, now somewhat better on valtrex
He had ME/CFS for about ten years, starting overnight, with a remission that ended after bowel surgery. COVID in 2024 left him bedbound for six to eight weeks; on valtrex, which he credits most, plus molnupiravir and Novavax, he improved to mild. He worked…
-
List of ME/CFS Recovery and Improvement Stories (page 7-8 discussion)
godlovesatrier fell ill after glandular fever in 2016 and was severe for about 18 months before building back to full-time work with herbal antivirals, high-dose thiamine, the Born Free protocol, valtrex and molnupiravir. He reached about 80–90% in…
-
Cured my Echovirus 11 (pretty sure)
sometexan84 fell ill in 2019 after an enterovirus infection that he says corticosteroid shots for sinus trouble made chronic; at his worst he could not work or care for his children. He credits peginterferon lambda, an Echovirus 11 antiviral cocktail and…
-
HHV-6/EBV testing UK? / Remitting symptoms on Molnupiravir?
FoxgloveFever had ME since 2006, varying from mild to severe, and was mostly bedbound for a year after catching COVID in 2022. A 2023 COVID reinfection treated with Molnupiravir was followed by a few weeks of feeling normal with no ME symptoms, but these…
-
Housebound with ME/CFS, symptoms vanished for a month after molnupiravir then returned
Ocean 26935 had CFS for 17 years with a fluctuating course from mild to severe. A Covid infection in early 2022 left them housebound and mostly in bed. After a second Covid infection in 2023 treated with molnupiravir, their Covid fatigue and brain fog took a…
-
ME/CFS able to work part-time, then COVID pain, fog; amitriptyline, gabapentin no benefit
They had ME/CFS since 2012, not severe, and had stabilised enough to work part-time. After COVID in late July 2026 they developed burning, pressure-sensitive pain, vertigo, light and noise sensitivity, brain fog and broken sleep, and said their baseline had…
-
ME/CFS fatigue: tirzepatide gave no symptom relief
A Reddit user with ME/CFS and ADHD, in their mid-40s, said Vyvanse gave them enough energy for a part-time job, though they remained fatigued. Two COVID infections did not make them worse, and Lagevrio made each illness tolerable. Tirzepatide, taken for over…
-
Barely able to walk with ME/CFS, much better after rest and time
A man in South Australia fell suddenly ill with a viral illness in 2020, was hospitalised and could barely walk to the letter box. He took a long sabbatical and credits complete rest, low stress and time, with antivirals, B12 injections, a CPAP machine and…
The first 5 credit Molnupiravir (Lagevrio) for their improvement; the other 3 tried it without crediting it.